ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00095706
Recruitment Status : Completed
First Posted : November 8, 2004
Last Update Posted : September 25, 2015
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by:
Translational Oncology Research International

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2007
  Actual Study Completion Date : January 2012